Condition

Oligoastrocytoma (2)

Anaplastic Oligoastrocytoma (1)

Anaplastic Oligodendroglioma (1)

Astrocytoma (1)

Glioma (1)

Mixed Glioma (1)

Oligodendroglioma (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 1/phase 2 (1)

phase 2 (1)

Sponsor

Keryx / AOI Pharmaceuticals, Inc. (1)

OHSU Knight Cancer Institute (1)

Collaborator

Oregon Health and Science University (1)

Intervention

carboplatin (1)

etoposide (1)

etoposide phosphate (1)

laboratory biomarker analysis (1)

mannitol (1)

melphalan (1)

quality-of-life assessment (1)

sodium thiosulfate (1)

temozolomide and o6-benzylguanine (1)

Study Documents

Intervention Type

drug (2)

other (1)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

Oligoastrocytoma

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma Trial in Minneapolis, Portland (Carboplatin, Etoposide,

Completed

Anaplastic Oligoastrocytoma
+3 more

Carboplatin
+7 more

Minneapolis, Minnesota
+1 more

Mar 11, 2022

Glioma, Astrocytoma, Oligodendroglioma Trial in United States (Temozolomide and O6-Benzylguanine)

Terminated

Glioma
+3 more

Temozolomide and O6-Benzylguanine

Los Angeles, California
+11 more

Feb 7, 2012